Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
Biotrial Constructs Clinical Pharmacology Unit
Biotrial is constructing the Clinical Pharmacology Unit in Newark, N.J. Located adjacent to Rutgers New Jersey Medical School in the University Heights Science Park, the 60,000-sf facility will support early development clinical studies in association with University Hospital. The project was designed by Francis Cauffman and is being built by Joseph A. Natoli Construction. Occupancy is expected in mid-2015.
Wake Forest Baptist Constructs Medical Education Facility
Wake Forest Baptist Medical Center will begin construction in early 2015 on a $50 million instructional facility for the School of Medicine in Winston-Salem, N.C. Located in the Wake Forest Innovation Quarter, the 168,000-sf building is designed to support one of the most advanced medical school curriculums in the country and will include technology-rich clinical simulation suites, small group learning spaces, an anatomy lab, offices, and meeting rooms. Occupancy is expected in July of 2016. The project developer is Wexford Science + Technology, LLC.
Missouri State University Builds Clinical Health Science Center
Missouri State University is building the $14.1 million O’Reilly Clinical Health Science Center in Springfield. The 55,000-sf facility will provide medical training labs, mannequin simulation suites, classrooms, offices, group study areas, and a multidisciplinary health clinic. The general contractor for the project is DeWitt & Associates. Completion is expected in fall of 2015.
Rajiv Gandhi National Centre for Biotechnology Plans BSL-4 Avian Flu Lab
Rajiv Gandhi National Centre for Biotechnology is planning to build a BSL-4 laboratory for avian influenza research in Thiruvananthapuram, India. The $9.7 million facility will be housed in the Microbial Containment Complex and will meet international safety standards. The project will support diagnostic testing for infectious diseases including H5N1, Ebola, Nipah, and Crimean Congo virus.
AstraZeneca Plans Cambridge R&D Headquarters
AstraZeneca will break ground in early 2015 on its $500 million Global R&D Centre and Corporate Headquarters in Cambridge in the United Kingdom. Providing sophisticated pharmaceutical discovery and development facilities, the project will include space for biologics research, high throughput screening, medicinal chemistry, pre-clinical research, and clinical development. The 11-acre campus will accommodate approximately 2,000 employees.